After docetaxel and androgen deprivation treatment, prostate cancer cells secreted more CXCL12 via TAMs,386 which helped cancer cells survive and reduced their sensitivity to chemotherapy by activating CXCR4. This evidence concerns the gene CXCL12 and cancer.